What does XOMA Royalty Corp (XOMA) do?

XOMA Royalty Corp (XOMA) is a publicly traded company in the Healthcare sector.

What sector does XOMA operate in?

XOMA Royalty Corp operates in the Healthcare, specifically within the Pharmaceuticals industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find XOMA earnings analysis?

AlphaOS publishes an earnings intelligence page for XOMA Royalty Corp (XOMA) covering results, guidance context, and AI-assisted analysis. See /stocks/XOMA/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 65%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

XOMA

XOMA Royalty Corp

Healthcare · Pharmaceuticals

$40.17Jul 13, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

XOMA Royalty Corp shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +208% YoY in Q1 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +208% YoY in Q1 FY2026

Pipeline evidence · 2d ago

XOMA's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on XOMA.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2026

Full XOMA earnings analysis

Reported figures for XOMA Royalty Corp — research only, not investment advice.

Revenue YoY: +208.0%
EPS YoY: +183.3%

Latest Intelligence

Updated September 27, 2026

What happened recently for XOMA Royalty Corp (XOMA) — events, not interpretation.

Event: Reported Q1 2026 revenue +208% YoY.
Also: Last session July 13, 2026 at $40.17.
Source: Q1 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

XOMA Royalty Corp (XOMA)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for XOMA Royalty Corp — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceuticals
Market cap:: $503.77M
Revenue:: $12.32M

XOMA earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow XOMA Royalty Corp through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Allogene Therapeutics, Inc.80% confidencerelated

Connected companies and research pages from the AlphaOS knowledge graph.